Redmile Group

company

Number of Investments

Number of Lead Investments

Redmile Group has made 25 investments. Their most recent investment was on May 25, 2022, when Rapt Therapeutics, Inc raised

Date	Company Name	Round	Money Raised	Industry	Lead Investor
May 25, 2022	Rapt Therapeutics	Post-IPO Equity	—	Biotechnology	Yes
Feb 16, 2022	Star Therapeutics	Series Unknown	—		—
Oct 7, 2021	Science 37	Post-IPO Equity	—	Biotechnology	—
Sep 9, 2021	Mammoth Biosciences	Series D	—	Biotechnology	Yes
Jul 13, 2021	Prime Medicine	Series B	—	Biotechnology	—
Jun 23, 2021	Strand Therapeutics	Series A	—	Biotechnology	—
Mar 31, 2021	Entrada Therapeutics	Series B	—	Biotechnology	—
Mar 23, 2021	Absci	Series Unknown	—	Artificial Intelligence	Yes
Jan 19, 2021	Verve Therapeutics	Series B	—	Biotechnology	—
Jan 19, 2021	Beam Therapeutics	Post-IPO Equity	—	Biotechnology	—
Dec 23, 2020	SomaLogic	Series A	—	Biotechnology	—
Nov 4, 2020	Mammoth Biosciences	Series C	—	Biotechnology	Yes
Oct 20, 2020	Absci	Series E	—	Artificial Intelligence	—
Aug 20, 2020	Science 37	Series Unknown	—	Biotechnology	Yes
Jul 9, 2019	BioNTech	Series B	—	Biopharma	—
Mar 6, 2019	Beam Therapeutics	Series B	—	Biotechnology	—
Jan 3, 2019	Science 37	Series D	—	Biotechnology	—
Jan 4, 2018	BioNTech	Series A	—	Biopharma	Yes
Sep 8, 2017	Replimune Group	Series B	—	Biotechnology	—
Apr 25, 2017	Science 37	Series C	—	Biotechnology	—
Oct 18, 2016	Science 37	Series B	—	Biotechnology	Yes
Nov 12, 2014	Blueprint Medicines	Series C	—	Bioinformatics	—
Oct 13, 2014	Invitae	Series F	—	Biotechnology	—
Dec 10, 2013	Invitae	Series E	—	Biotechnology	—
Apr 26, 2011	Oxford Nanopore Technologies	Series Unknown	—	Biopharma	—